04/11/2024
8:17 AM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:59 PM | Corbus Pharmaceuticals (Filer)
| Form DEFA14A | |
03/22/2024
4:05 PM | Corbus Pharmaceuticals (Filer)
| Form PRE 14A | |
03/20/2024
11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
03/20/2024
4:07 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
03/20/2024
4:10 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K/A | |
|
03/20/2024
4:13 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:52 PM | Corbus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/12/2024
4:19 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2024
7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:34 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:13 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
3:45 PM | Corbus Pharmaceuticals (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
2:19 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:26 PM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:47 PM | Corbus Pharmaceuticals (Subject)
Cormorant Global Healthcare Master Fund, LP (Filed by)
| Form SC 13G | |
02/05/2024
7:12 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
7:55 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K/A | |
02/01/2024
4:27 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:09 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/31/2024
8:16 AM | Corbus Pharmaceuticals (Filer)
| Form S-3MEF | |
01/30/2024
7:40 PM | Corbus Pharmaceuticals (Filer)
| Form 424B5 | |
01/30/2024
7:41 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
5:07 PM | Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:56 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:18 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/30/2024
3:23 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:40 PM | Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/29/2024
6:30 AM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
01/29/2024
6:31 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
7:45 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:25 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:57 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
8:23 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:21 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
8:05 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:44 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
11:15 PM | Corbus Pharmaceuticals (Filer)
| Form EFFECT | |
06/13/2023
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 424B3 | |
Will this $2 AI stock double overnight? (Ad) It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract.
What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> |
06/12/2023
3:53 PM | Corbus Pharmaceuticals (Filer)
| Form S-3/A | |
05/31/2023
8:05 PM | Corbus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2023
3:32 PM | Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:33 PM | Altmeyer Anne (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:17 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:20 PM | Ben Yong (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:22 PM | Corbus Pharmaceuticals (Issuer)
HOLMER ALAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:24 PM | Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:01 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2023
3:39 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K/A | |
